OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2015 | $310,000 | Replaced |
| 3rd Quarter - Amendment | Mar 22, 2016 | $290,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping Families in Mental Health Crisis Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN BARDI New | — |
| MOLLY RYAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.